Clinical Trials Study
Copyright ©The Author(s) 2020.
World J Gastrointest Surg. Dec 27, 2020; 12(12): 520-533
Published online Dec 27, 2020. doi: 10.4240/wjgs.v12.i12.520
Table 4 Clinical characteristics of combination low alpha-fetoprotein/gamma glutamyl transpeptidase patients vs all other combinations
ParametersLow AFP ≤ 200, low GGT ≤ 104, n = 14Other combos, n = 34P value
AFP (ng/mL)
Median7.35132.50.009b
mean ± SD21.6 ± 32.4758.5 ± 2397.2
GGT (IU/L)
Median63140.5< 0.001c
mean ± SD59.6 ± 31.6208.9 ± 232.4
Total Bilirubin (mg/dL)
Median21.40.511
mean ± SD3.2 ± 3.82.5 ± 3.0
AST (IU/L)
Median68.577.50.892
mean ± SD126.2 ± 145.993.2 ± 66.4
MTD (cm)
Median8.758.250.317
mean ± SD8.66 ± 1.189.9 ± 4.5
Number of nodules, n (%)
18 (57)14 (41)0.490
> 16 (43)20 (59)
Microvascular invasion, n (%)
Negative7 (50)7 (21)0.041a
Positive7 (50)27 (79)
Differentiation, n (%)
Well7 (50)7 (20)0.020a
Moderate5 (36)19 (56)
Poor2 (14)8 (24)